Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gerson

Showing results (191-200 of 257) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive daysA Dowlati, C L Hoppel, S T Ingalls, et al.
International Journal of Stem Cell Research and Therapy|August 30, 2016
Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell Clones is Defined by the Promoter CpG Methylation Pattern Observed by High-Throughput Methylation Specific SequencingJonathan Kenyon, Gabrielle Nickel-Meester, Yulan Qing, et al.
Haematologica|February 24, 2018
A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor supportAmar Desai, Yongyou Zhang, Youngsoo Park, et al.
Journal of Clinical Pharmacology|September 5, 2003
Pharmacokinetics of O6-benzylguanine (NSC637037) and its metabolite, 8-oxo-O6-benzylguanineKou-Yi Tserng, Stephen T Ingalls, Erik M Boczko, et al.
Leukemia|October 3, 2018
Mlh1 deficiency increases the risk of hematopoietic malignancy after simulated space radiation exposureRutulkumar Patel, Luchang Zhang, Amar Desai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 14, 2016
Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamineNancy L Oleinick, Tithi Biswas, Rutulkumar Patel, et al.
Cancers|February 6, 2021
Socioeconomic Factors and Survival of Multiple Myeloma PatientsKamal Chamoun, Amin Firoozmand, Paolo Caimi, et al.
Molecular Cancer Therapeutics|January 25, 2006
Differential competitive resistance to methylating versus chloroethylating agents among five O6-alkylguanine DNA alkyltransferases in human hematopoietic cellsAparecida Maria Fontes, Brian M Davis, Lance P Encell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSFO N Koç, S L Gerson, B W Cooper, et al.
Cancer Research|March 15, 1990
High level, regulated expression of the chimeric P-enolpyruvate carboxykinase (GTP)-bacterial O6-alkylguanine-DNA alkyltransferase (ada) gene in transgenic miceI K Lim, L L Dumenco, J Yun, et al.
Pageof 26

Showing results (191-200 of 257) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive daysA Dowlati, C L Hoppel, S T Ingalls, et al.
International Journal of Stem Cell Research and Therapy|August 30, 2016
Epigenetic Loss of MLH1 Expression in Normal Human Hematopoietic Stem Cell Clones is Defined by the Promoter CpG Methylation Pattern Observed by High-Throughput Methylation Specific SequencingJonathan Kenyon, Gabrielle Nickel-Meester, Yulan Qing, et al.
Haematologica|February 24, 2018
A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor supportAmar Desai, Yongyou Zhang, Youngsoo Park, et al.
Journal of Clinical Pharmacology|September 5, 2003
Pharmacokinetics of O6-benzylguanine (NSC637037) and its metabolite, 8-oxo-O6-benzylguanineKou-Yi Tserng, Stephen T Ingalls, Erik M Boczko, et al.
Leukemia|October 3, 2018
Mlh1 deficiency increases the risk of hematopoietic malignancy after simulated space radiation exposureRutulkumar Patel, Luchang Zhang, Amar Desai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 14, 2016
Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamineNancy L Oleinick, Tithi Biswas, Rutulkumar Patel, et al.
Cancers|February 6, 2021
Socioeconomic Factors and Survival of Multiple Myeloma PatientsKamal Chamoun, Amin Firoozmand, Paolo Caimi, et al.
Molecular Cancer Therapeutics|January 25, 2006
Differential competitive resistance to methylating versus chloroethylating agents among five O6-alkylguanine DNA alkyltransferases in human hematopoietic cellsAparecida Maria Fontes, Brian M Davis, Lance P Encell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSFO N Koç, S L Gerson, B W Cooper, et al.
Cancer Research|March 15, 1990
High level, regulated expression of the chimeric P-enolpyruvate carboxykinase (GTP)-bacterial O6-alkylguanine-DNA alkyltransferase (ada) gene in transgenic miceI K Lim, L L Dumenco, J Yun, et al.
Pageof 26